Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Connect Biopharma Holdings Limited Sponsored ADR (CNTB) had Return on Tangible Equity of -45.56% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$0.17M |
|
$-19.40M |
|
-- |
|
$0.17M |
|
$19.78M |
|
$-19.61M |
|
$0.26M |
|
$-19.35M |
|
$-19.35M |
|
$-19.40M |
|
$-19.40M |
|
$-19.40M |
|
$-19.40M |
|
$-19.61M |
|
$-19.44M |
|
56.55M |
|
56.55M |
|
$-0.34 |
|
$-0.34 |
|
| Balance Sheet Financials | |
$55.02M |
|
$3.70M |
|
$5.05M |
|
$60.07M |
|
$17.05M |
|
$0.29M |
|
$0.40M |
|
$17.44M |
|
$42.62M |
|
$42.58M |
|
$42.62M |
|
62.71M |
|
| Cash Flow Statement Financials | |
$-16.00M |
|
$6.00M |
|
$17.62M |
|
$38.34M |
|
$46.03M |
|
$7.69M |
|
$1.20M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.23 |
|
-- |
|
-- |
|
0.01 |
|
0.02 |
|
100.00% |
|
-11601.77% |
|
-11601.77% |
|
-- |
|
-11449.71% |
|
-11478.11% |
|
$-16.00M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.02 |
|
4785.44 |
|
-45.51% |
|
|
Return on Tangible Equity |
-45.56% |
-32.29% |
|
-45.21% |
|
$0.68 |
|
$-0.28 |
|
$-0.28 |
|